| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.093 | 0.002 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |